Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
Max Jan(Broad Institute), Benjamin L. Ebert(Dana-Farber Cancer Institute), Andrea Schmidts(Harvard University), Quinlan Sievers(Broad Institute), Andrew A. Guirguis(Peter MacCallum Cancer Centre), Irene Scarfò(Harvard University), Marcela V. Maus(Center for Cancer Research), Mikołaj Słabicki(Broad Institute), Michael C. Kann(Massachusetts General Hospital), Alexander Tepper(Broad Institute), Ana P. Castaño(Harvard University), Rebecca C. Larson(Harvard University), Amanda Walker(Broad Institute), Amanda A. Bouffard(Harvard University), Daniel E. Grinshpun(Broad Institute), Taeyoon Kyung(Allen Institute), Adam S. Sperling(Dana-Farber Cancer Institute), Michael E. Birnbaum(Ragon Institute of MGH, MIT and Harvard), Jessica A. Gasser(Broad Institute), Maria L. Cabral(Harvard University)
Cited by 257
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k